Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for ...

Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicineHOLLY SPRINGS, N.C., April 23, 2025 -- ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

Attovia Therapeutics has completed an oversubscribed $90 million Series C financing, which the company plans to use along with existing cash and investments to advance its two lead pipeline candidates ...

Earth Day 2025 calls for a bold global effort to triple renewable electricity generation by 2030. The world of sport is ...

“The Exact Sciences team is off to a good start in 2025, building on the momentum ... of analysts’ EPS estimates. Regeneron had the weakest performance against analyst estimates among its peers. The ...

Celldex’s cash runway extends into 2027, but potential delays or hurdles could necessitate earlier fundraising, exerting ...

NetRise, the leader in software supply chain security ? helping companies inventory software assets and identify and respond to software risk ? today announced three key executive hires to its ...

He’s worked at Regeneron, Medimmune ... Guralnik founded Synergy Research after building his career at Amgen. TScan recruits market access executive. TScan Therapeutics, a clinical-stage ...